Investigational Drug Information for Tamibarotene
✉ Email this page to a colleague
What is the drug development status for Tamibarotene?
Tamibarotene is an investigational drug.
There have been 11 clinical trials for Tamibarotene.
The most recent clinical trial was a Phase 2 trial, which was initiated on February 8th 2021.
The most common disease conditions in clinical trials are Leukemia, Myelodysplastic Syndromes, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are CytRx, Syros Pharmaceuticals, and Cephalon.
There are four hundred and seventeen US patents protecting this investigational drug and four international patents.
Summary for Tamibarotene
| US Patents | 417 |
| International Patents | 4,019 |
| US Patent Applications | 1,496 |
| WIPO Patent Applications | 737 |
| Japanese Patent Applications | 303 |
| Clinical Trial Progress | Phase 2 (2021-02-08) |
| Vendors | 102 |
Recent Clinical Trials for Tamibarotene
| Title | Sponsor | Phase |
|---|---|---|
| SY-1425 Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed AML | Syros Pharmaceuticals | Phase 2 |
| Investigator-initiated Clinical Trial of MIKE-1 | Japan Agency for Medical Research and Development | Phase 1/Phase 2 |
| Investigator-initiated Clinical Trial of MIKE-1 | Nagoya University | Phase 1/Phase 2 |
Clinical Trial Summary for Tamibarotene
Top disease conditions for Tamibarotene
Top clinical trial sponsors for Tamibarotene
US Patents for Tamibarotene
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tamibarotene | ⤷ Try a Trial | Anticancer agent | Kyoto Pharmaceutical Industries, Ltd. (Kyoto, JP) Sumitomo Dainippon Pharma Co., Ltd. (Osaka, JP) | ⤷ Try a Trial |
| Tamibarotene | ⤷ Try a Trial | Pyrrolidinone derivatives as MetAP-2 inhibitors | Merck Patent GmbH (Darmstadt, DE) | ⤷ Try a Trial |
| Tamibarotene | ⤷ Try a Trial | .beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof | Quadriga Biosciences, Inc. (Los Altos, CA) | ⤷ Try a Trial |
| Tamibarotene | ⤷ Try a Trial | Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tamibarotene
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tamibarotene | Australia | AU2015272560 | 2034-06-09 | ⤷ Try a Trial |
| Tamibarotene | Canada | CA2951627 | 2034-06-09 | ⤷ Try a Trial |
| Tamibarotene | Denmark | DK3153508 | 2034-06-09 | ⤷ Try a Trial |
| Tamibarotene | European Patent Office | EP3153508 | 2034-06-09 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
